Odyssey Therapeutics

IPO

Transforming the standard of care

Boston, United States · Founded 2021 · $700.0M raised

Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$700.0M
Last Round
$213.0M Series DSep 2025
Rounds
4

About

Odyssey Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule and protein therapeutics for autoimmune and inflammatory diseases. Founded in 2021 and based in Boston, Odyssey uses a replicable and scalable drug discovery model combining AI-driven small molecule design with precision targeting of the innate immune system. The company has raised over $400 million across multiple financing rounds including a $213 million Series D in 2025.

Summary

Odyssey Therapeutics is a Biotech company based in Boston, United States, founded in 2021. It has raised $700.0M in total across 4 rounds, most recently a $213.0M Series D round in Sep 2025. Investors include SR One, Ascenta Capital and Lightspeed VP.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOMay 2026
$279.0M

Sign up to see all 5 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Odyssey Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/odyssey-therapeutics"><img src="https://indexed.vc/api/badge/company/odyssey-therapeutics" alt="Odyssey Therapeutics on Indexed.vc" width="260" height="76" /></a>